Project Grant HT94252410230

Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $399K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
This $2,428,329 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support The University of Iowa in expanding and accelerating access to care for Achilles tendinopathy through self-management rehabilitation strategies. The funding will enable the university to conduct research and develop innovative solutions to improve treatment outcomes and patient self-care for this medical condition commonly affecting...
The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
This $1,399,501 federal Project Grant awarded by the Defense Health Agency on September 1, 2023 will fund the development of a novel DNA aptamer-based IFN-γ targeted therapy for chronic cystitis pain at the University of Iowa. The project, which is scheduled for completion by August 31, 2027, aligns with the objectives of the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to transform healthcare for Service Members and the American public through...
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The University of Iowa was awarded a $311,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying the temporal and spatial origins and reversibility of neurodevelopmental disorders with autism in mouse models. The grant, awarded on June 1, 2024, will fund this research project through May 31, 2026. The Military Medical Research and Development program supports biomedical...
The University of Iowa received a $598,563 Project Grant from the Department of Defense Washington Headquarters Service to support basic scientific research related to or with potential to improve Army programs under the Basic Scientific Research federal grant program (CFDA 12.431). Specifically, the grant will fund research and development of a Constellation Ready Magnetometer from July 1, 2021 to June 30, 2024. The University of Iowa will conduct the research at its location in Iowa City,...
The University of Utah received a $1,499,903 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "HIGH-PERFORMANCE POWERED ANKLE/FOOT PROSTHESIS FOR BELOW-KNEE AMPUTEES". The award has a performance period from August 1, 2024 to July 31, 2028. As part of this grant, the University of Utah is collaborating with a subrecipient, Otto Bock Healthcare LP, a prosthetics manufacturer, to design and produce...
This federal Project Grant award from the Office of Naval Research (CFDA 12.300 - Basic and Applied Scientific Research) provides $113,500.00 to the University of Iowa to conduct a Computational Fluid Dynamics (CFD) study supporting naval maneuvering analysis and modeling efforts. The award, which runs from July 1, 2025 through June 30, 2029, will enable the university to investigate transient maneuvering physics and develop advanced modeling and artificial intelligence capabilities to support...

This $399,496 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The University of Iowa to study the effects of heel clearance on foot loading with carbon fiber custom dynamic orthoses. The grant period runs from July 1, 2024 to June 30, 2026. The University of Iowa, a major public research university, will leverage its expertise in medicine, engineering, and specialized laboratory services to conduct this innovative research project aimed at improving health outcomes for military service members and the broader public. The grant supports the university's capacity to deliver scientific solutions and advance knowledge in support of federal missions.

Generated 4/1/25, 1:55 AM